We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Brookdale Senior Living, The Ensign Group, Amedysis and Chemed
Read MoreHide Full Article
For Immediate Release
Chicago, IL – May 27, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Brookdale Senior Living (BKD - Free Report) , The Ensign Group (ENSG - Free Report) , Amedysis (AMED - Free Report) and Chemed (CHE - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
"Silver Tsunami" to Hit U.S.: 4 Stocks in Focus
America’s increasing aging population will eventually lead to the phenomenon of “silver tsunami” wherein older people outnumber the younger generation. Per the U.S. Census Bureau’s latest report, all baby boomers are projected to turn 65 or older by 2030.
This massive demographic shift will benefit companies that cater to the needs of seniors.
What’s Behind the Shift?
Progress in medical science and new insights into lifestyle and other environmental influences are allowing a growing number of people to remain healthy in their advanced years. With an increasing portion of the U.S. population achieving higher levels of education and better standard of living, as well as experiencing increasingly lower rates of disability, people are living longer.
Consequently, the number of people aged 65 years and older in the United States has grown rapidly, from 3.1 million in 1900 to 35 million in 2000.
While improved healthcare facilities have been boosting life span, record low birth rates among young women have been contributing to the nation’s greying population, as stated by John Haaga from the National Institute of Aging.
Notably, the total fertility rate of U.S. women is now 1.7 children per woman, below 2.1 children needed to replace the population. On the other hand, life expectancy at age 65 went from 11.9 years (1900-1902) to 19.1 years in 2010, according to An Aging World, a Census Bureau report.
Key Projections
Older adults are projected to outnumber children under 18 for the first time in U.S. history by 2034, according to Census Bureau projections. Currently, there are approximately 35 million Americans aged 65 or older and this number is expected to double in the next 25 years.
Stocks in Focus
Considering the aforementioned projections, it is prudent to conclude that all kinds of businesses involved in senior care, including those that provide assisted living to elders as well as hospice care givers, will benefit from this trend. We have discussed some of these stocks below:
Brookdale Senior Living: It is a leading owner and operator of senior living facilities throughout the United States. Brookdale operates and manages independent living, assisted living, memory care and continuing care retirement centers. The company sports a Zacks Rank #1 (Strong Buy) and has a four-quarter average positive earnings surprise of 2.33%. You can see the complete list of today's Zacks #1 Rank stocks here.
The Ensign Group: The company’s affiliated entities offer a broad spectrum of post-acute care including senior living, skilled nursing, and rehabilitative care. As of Mar 31, 2020, its operating subsidiaries had a collective capacity of approximately 22,900 operational skilled nursing beds and 2,100 senior living units. The company carries a Zacks Rank #2 (Buy) and has a four-quarter average positive earnings surprise of 7.87%.
Amedysis: It provides home health and hospice services to the growing chronic, co-morbid, and aging American population. As of Mar 31, 2020, the company owned and operated 322 Medicare-certified home health care centers, 146 Medicare-certified hospice care centers and 12 personal-care care centers in 38 states within the United States and the District of Columbia. Amedysis carries a Zacks Rank #3 (Hold) and has a four-quarter average positive earnings surprise of 15.46%.
Chemed: This company’s subsidiary VITAS Healthcare is the nation’s leading provider of end-of-life care. There are 12,262 VITAS professionals providing care to approximately 19,215 patients daily throughout 14 U.S. states and the District of Columbia. Chemed carries a Zacks Rank #3 and has a four-quarter average positive earnings surprise of 4.42%.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Brookdale Senior Living, The Ensign Group, Amedysis and Chemed
For Immediate Release
Chicago, IL – May 27, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Brookdale Senior Living (BKD - Free Report) , The Ensign Group (ENSG - Free Report) , Amedysis (AMED - Free Report) and Chemed (CHE - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
"Silver Tsunami" to Hit U.S.: 4 Stocks in Focus
America’s increasing aging population will eventually lead to the phenomenon of “silver tsunami” wherein older people outnumber the younger generation. Per the U.S. Census Bureau’s latest report, all baby boomers are projected to turn 65 or older by 2030.
This massive demographic shift will benefit companies that cater to the needs of seniors.
What’s Behind the Shift?
Progress in medical science and new insights into lifestyle and other environmental influences are allowing a growing number of people to remain healthy in their advanced years. With an increasing portion of the U.S. population achieving higher levels of education and better standard of living, as well as experiencing increasingly lower rates of disability, people are living longer.
Consequently, the number of people aged 65 years and older in the United States has grown rapidly, from 3.1 million in 1900 to 35 million in 2000.
While improved healthcare facilities have been boosting life span, record low birth rates among young women have been contributing to the nation’s greying population, as stated by John Haaga from the National Institute of Aging.
Notably, the total fertility rate of U.S. women is now 1.7 children per woman, below 2.1 children needed to replace the population. On the other hand, life expectancy at age 65 went from 11.9 years (1900-1902) to 19.1 years in 2010, according to An Aging World, a Census Bureau report.
Key Projections
Older adults are projected to outnumber children under 18 for the first time in U.S. history by 2034, according to Census Bureau projections. Currently, there are approximately 35 million Americans aged 65 or older and this number is expected to double in the next 25 years.
Stocks in Focus
Considering the aforementioned projections, it is prudent to conclude that all kinds of businesses involved in senior care, including those that provide assisted living to elders as well as hospice care givers, will benefit from this trend. We have discussed some of these stocks below:
Brookdale Senior Living: It is a leading owner and operator of senior living facilities throughout the United States. Brookdale operates and manages independent living, assisted living, memory care and continuing care retirement centers. The company sports a Zacks Rank #1 (Strong Buy) and has a four-quarter average positive earnings surprise of 2.33%. You can see the complete list of today's Zacks #1 Rank stocks here.
The Ensign Group: The company’s affiliated entities offer a broad spectrum of post-acute care including senior living, skilled nursing, and rehabilitative care. As of Mar 31, 2020, its operating subsidiaries had a collective capacity of approximately 22,900 operational skilled nursing beds and 2,100 senior living units. The company carries a Zacks Rank #2 (Buy) and has a four-quarter average positive earnings surprise of 7.87%.
Amedysis: It provides home health and hospice services to the growing chronic, co-morbid, and aging American population. As of Mar 31, 2020, the company owned and operated 322 Medicare-certified home health care centers, 146 Medicare-certified hospice care centers and 12 personal-care care centers in 38 states within the United States and the District of Columbia. Amedysis carries a Zacks Rank #3 (Hold) and has a four-quarter average positive earnings surprise of 15.46%.
Chemed: This company’s subsidiary VITAS Healthcare is the nation’s leading provider of end-of-life care. There are 12,262 VITAS professionals providing care to approximately 19,215 patients daily throughout 14 U.S. states and the District of Columbia. Chemed carries a Zacks Rank #3 and has a four-quarter average positive earnings surprise of 4.42%.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.